Page last updated: 2024-08-17

n-vinyl-2-pyrrolidinone and Incontinentia Pigmenti Achromians

n-vinyl-2-pyrrolidinone has been researched along with Incontinentia Pigmenti Achromians in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
IGARASHI, T1
Addy, M; Claydon, N; Darby-Dowman, A; Manning, CM; Ridge, D; Smith, S1
GĂ©niaux, M; Le Coulant, P; Leuret, J; Texier, L1

Trials

1 trial(s) available for n-vinyl-2-pyrrolidinone and Incontinentia Pigmenti Achromians

ArticleYear
The effect of polyvinyl pyrrolidone on the clinical activity of 0.09% and 0.2% chlorhexidine mouthrinses.
    Journal of clinical periodontology, 2001, Volume: 28, Issue:11

    Topics: Adult; Analysis of Variance; Anti-Infective Agents, Local; Chlorhexidine; Confidence Intervals; Cross-Over Studies; Dental Calculus; Dental Plaque; Dose-Response Relationship, Drug; Drug Interactions; Female; Follow-Up Studies; Gingivitis; Humans; Male; Middle Aged; Mouthwashes; Oils, Volatile; Pigmentation Disorders; Placebos; Povidone; Single-Blind Method; Statistics as Topic; Statistics, Nonparametric; Tongue Diseases; Tooth Discoloration; Treatment Outcome

2001

Other Studies

2 other study(ies) available for n-vinyl-2-pyrrolidinone and Incontinentia Pigmenti Achromians

ArticleYear
[A CASE OF IDIOPATHIC HYPERCATABOLIC HYPOPROTEINEMIA ASSOCIATED WITH ABNORMAL PIGMENTATION].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1964, May-10, Volume: 53

    Topics: Blood Protein Disorders; Humans; Hypoproteinemia; Pigmentation; Pigmentation Disorders; Povidone; Protein-Losing Enteropathies; Proteins; Serum Albumin; Tryptophan

1964
[Iconography of a case of thesaurismosis caused by posterior pituitary polyvidone].
    Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1967, Volume: 74, Issue:5

    Topics: Adult; Diabetes Insipidus; Female; Humans; Metabolic Diseases; Obesity; Pigmentation Disorders; Povidone; Skin Diseases; Vascular Diseases

1967